Market Cap ₹17 Cr.
Stock P/E
P/B 1.2
Current Price ₹33.3
Book Value ₹ 28.7
Face Value 10
52W High ₹42.9
Dividend Yield 0%
52W Low ₹ 0
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) |
---|
Net Sales |
Other Income |
Total Income |
Total Expenditure |
Operating Profit |
Interest |
Depreciation |
Exceptional Income / Expenses |
Profit Before Tax |
Provision for Tax |
Profit After Tax |
Adjustments |
Profit After Adjustments |
Adjusted Earnings Per Share |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 13 | 16 | 20 | 19 | 23 | 20 | 8 | 19 | 30 | |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Total Income | 14 | 16 | 21 | 20 | 23 | 20 | 8 | 19 | 30 | |
Total Expenditure | 13 | 15 | 19 | 18 | 21 | 19 | 8 | 17 | 27 | |
Operating Profit | 1 | 1 | 1 | 2 | 2 | 1 | 0 | 2 | 3 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Profit Before Tax | 1 | 1 | 1 | 1 | 2 | 1 | 0 | 1 | 3 | |
Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |
Profit After Tax | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 2 | |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Profit After Adjustments | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 2 | |
Adjusted Earnings Per Share | 1.4 | 1.7 | 2.4 | 2.7 | 3.5 | 1.1 | 0.3 | 3.1 | 3.8 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 58% | 14% | 10% | 0% |
Operating Profit CAGR | 50% | 44% | 8% | 0% |
PAT CAGR | 100% | 0% | 15% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 10% | NA% | NA% | NA% |
ROE Average | 17% | 11% | 13% | 21% |
ROCE Average | 23% | 16% | 17% | 23% |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 2 | 2 | 3 | 4 | 5 | 7 | 7 | 8 | 15 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 0 |
Other Non-Current Liabilities | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 0 | 0 |
Total Current Liabilities | 2 | 6 | 4 | 3 | 8 | 5 | 4 | 5 | 4 |
Total Liabilities | 5 | 9 | 7 | 8 | 14 | 13 | 12 | 13 | 19 |
Fixed Assets | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Current Assets | 5 | 9 | 7 | 8 | 13 | 12 | 11 | 12 | 18 |
Total Assets | 5 | 9 | 7 | 8 | 14 | 13 | 12 | 13 | 19 |
#(Fig in Cr.) | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 3 | 2 |
Cash Flow from Operating Activities | -0 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 1 |
Cash Flow from Investing Activities | -0 | -1 | -0 | -0 | -0 | -0 | 0 | -0 | -0 |
Cash Flow from Financing Activities | 0 | -0 | -0 | 0 | -0 | -1 | -1 | -1 | 4 |
Net Cash Inflow / Outflow | -0 | 0 | -0 | 0 | 1 | -0 | 1 | -0 | 5 |
Closing Cash & Cash Equivalent | 0 | 0 | 0 | 0 | 2 | 2 | 3 | 2 | 7 |
# | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 1.42 | 1.74 | 2.36 | 2.72 | 3.46 | 1.14 | 0.28 | 3.14 | 3.83 |
CEPS(Rs) | 1.46 | 1.88 | 2.58 | 2.98 | 3.88 | 1.57 | 0.69 | 3.55 | 4.23 |
DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.5 |
Book NAV/Share(Rs) | 4.64 | 6.38 | 8.74 | 11.45 | 14.91 | 20.59 | 20.87 | 24.02 | 28.65 |
Core EBITDA Margin(%) | 3.68 | 4.66 | 4.92 | 6.3 | 7.43 | 3.71 | 3.72 | 9.65 | 8.8 |
EBIT Margin(%) | 5.74 | 6.21 | 6.65 | 7.91 | 7.72 | 3.69 | 4.21 | 9.36 | 9.01 |
Pre Tax Margin(%) | 5.34 | 5.47 | 6.07 | 7.32 | 7.25 | 2.66 | 1.69 | 7.81 | 8.79 |
PAT Margin (%) | 3.69 | 3.77 | 4.06 | 4.86 | 5.19 | 1.95 | 1.24 | 5.84 | 6.58 |
Cash Profit Margin (%) | 3.8 | 4.08 | 4.45 | 5.32 | 5.81 | 2.69 | 3.04 | 6.6 | 7.25 |
ROA(%) | 10.62 | 8.93 | 10.12 | 12.38 | 11.07 | 2.92 | 0.78 | 8.64 | 12.22 |
ROE(%) | 30.64 | 31.61 | 31.22 | 26.93 | 26.23 | 6.4 | 1.36 | 14 | 17.12 |
ROCE(%) | 27.94 | 29.59 | 32.4 | 33.43 | 30.7 | 9.48 | 3.79 | 20.28 | 22.77 |
Receivable days | 104.83 | 123.39 | 107.55 | 97.06 | 121.69 | 164.35 | 352.81 | 151.79 | 105.41 |
Inventory Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Payable days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
PER(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 |
Price/Book(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.8 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.17 |
EV/Net Sales(x) | 0.06 | 0.02 | -0.01 | -0.04 | 0.08 | 0.16 | 0.26 | 0.09 | 0.16 |
EV/Core EBITDA(x) | 0.94 | 0.32 | -0.18 | -0.52 | 0.95 | 3.62 | 4.38 | 0.84 | 1.63 |
Net Sales Growth(%) | 0 | 19.66 | 25.92 | -3.59 | 19.06 | -12.69 | -61.16 | 137.82 | 61.38 |
EBIT Growth(%) | 0 | 29.56 | 34.86 | 14.6 | 16.24 | -58.27 | -55.68 | 428.66 | 55.36 |
PAT Growth(%) | 0 | 22.47 | 35.49 | 15.26 | 27.17 | -67.14 | -75.25 | 1017.3 | 81.73 |
EPS Growth(%) | 0 | 22.47 | 35.49 | 15.26 | 27.17 | -67.14 | -75.25 | 1017.3 | 22.03 |
Debt/Equity(x) | 0.71 | 0.8 | 0.42 | 0.23 | 0.3 | 0.26 | 0.17 | 0.05 | 0.02 |
Current Ratio(x) | 1.86 | 1.43 | 1.86 | 2.37 | 1.74 | 2.21 | 2.56 | 2.49 | 4.27 |
Quick Ratio(x) | 1.86 | 1.43 | 1.86 | 2.37 | 1.74 | 2.21 | 2.56 | 2.49 | 4.27 |
Interest Cover(x) | 14.31 | 8.35 | 11.36 | 13.36 | 16.23 | 3.57 | 1.67 | 6.04 | 41.23 |
Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.02 |
# | Mar 2018 | Mar 2023 | Sep 2023 | Mar 2024 |
---|---|---|---|---|
Promoter | 96.66 | 64.91 | 65.14 | 65.22 |
FII | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 |
Public | 3.34 | 35.09 | 34.86 | 34.78 |
Others | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 |
# | Mar 2018 | Mar 2023 | Sep 2023 | Mar 2024 |
---|---|---|---|---|
Promoter | 0.34 | 0.34 | 0.34 | 0.34 |
FII | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 |
Public | 0.01 | 0.18 | 0.18 | 0.18 |
Others | 0 | 0 | 0 | 0 |
Total | 0.35 | 0.52 | 0.52 | 0.52 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About